ArriVent BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVBP and other ETFs, options, and stocks.About AVBP
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
CEOZheng Bin Yao
CEOZheng Bin Yao
Employees52
Employees52
HeadquartersNewtown Square, Pennsylvania
HeadquartersNewtown Square, Pennsylvania
Founded2021
Founded2021
Employees52
Employees52
AVBP Key Statistics
Market cap1.01B
Market cap1.01B
Price-Earnings ratio-5.77
Price-Earnings ratio-5.77
Dividend yield—
Dividend yield—
Average volume453.61K
Average volume453.61K
High today$24.76
High today$24.76
Low today$23.52
Low today$23.52
Open price$23.52
Open price$23.52
Volume194.24K
Volume194.24K
52 Week high$29.71
52 Week high$29.71
52 Week low$15.47
52 Week low$15.47
Stock Snapshot
The current ArriVent BioPharma(AVBP) stock price is $24.42, with a market capitalization of 1.01B. The stock trades at a price-to-earnings (P/E) ratio of -5.77.
On 2025-12-14, ArriVent BioPharma(AVBP) stock traded between a low of $23.52 and a high of $24.76. Shares are currently priced at $24.42, which is +3.8% above the low and -1.4% below the high.
The ArriVent BioPharma(AVBP)'s current trading volume is 194.24K, compared to an average daily volume of 453.61K.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $29.71 and a 52-week low of $15.47.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $29.71 and a 52-week low of $15.47.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AVBP. This list is generated using Robinhood data, and it’s not a recommendation.